EDSA
Edesa Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$2.78
+8.17%Next report
Analyst consensus
- Next report date
- Dec 11, 2026
- EPS estimate
- -$0.58
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.60
- EPS estimate
- -$0.43
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -40.2%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.43 | -$0.60 | Miss -37.93% | — |
| May 14, 2026 | -$0.24 | -$0.49 | Miss -104.17% | — |
| Feb 13, 2026 | -$0.28 | -$0.28 | In line | — |
| Dec 12, 2025 | -$0.27 | -$0.32 | Miss -18.52% | — |
| Aug 8, 2025 | -$0.26 | -$0.25 | Beat 3.85% | — |
| May 14, 2025 | -$0.30 | -$0.30 | In line | — |
| Feb 14, 2025 | -$0.31 | -$0.48 | Miss -54.84% | — |
| Dec 13, 2024 | -$0.54 | -$0.29 | Beat 46.30% | — |
| Aug 9, 2024 | -$0.58 | -$0.52 | Beat 10.34% | — |
| May 10, 2024 | -$0.69 | -$0.58 | Beat 15.94% | — |
| Feb 9, 2024 | -$1.21 | -$0.54 | Beat 55.37% | — |
| Dec 15, 2023 | -$0.71 | -$0.60 | Beat 15.49% | -$1.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 11, 2026